Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001013594-25-001501
Filing Date
2025-12-10
Accepted
2025-12-10 20:51:19
Documents
1
Period of Report
2025-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 3932
  Complete submission text file 0001013594-25-001501.txt   5747
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1707
EXICURE, INC. (Issuer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 22F, PARC.1, 108, YEOUI-DAERO YEONGDEUNGPO-GU SEOUL Korea, Republic of
Business Address 22F, PARC.1, 108, YEOUI-DAERO YEONGDEUNGPO-GU SEOUL Korea, Republic of 82-2-1566-0900
SANGSANGIN INVESTMENT & SECURITIES CO., LTD. (Reporting) CIK: 0002049712 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39011 | Film No.: 251563297